Prostatis Group LLC Goldman Sachs ETF Tr Actvebeta Transaction History

Prostatis Group LLC

  • $349 Billion
  • Q2 2025

A detailed history of Prostatis Group LLC transactions in Goldman Sachs ETF Tr Actvebeta stock. As of the latest transaction made, Prostatis Group LLC holds 32,539 shares of GEM stock, worth $1.24 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
32,539
Previous 15,901 104.63%
Holding current value
$1.24 Million
Previous $528 Million 129.49%
% of portfolio
0.35%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 25, 2025
BUY
$29.41 - $37.21 $489,323 - $619,099
16,638 Added 104.63%
32,539 $1.21 Billion
Q1 2025

May 16, 2025
BUY
$31.09 - $34.34 $132,412 - $146,254
4,259 Added 36.58%
15,901 $528 Million
Q4 2024

Mar 21, 2025
BUY
$31.92 - $36.14 $371,612 - $420,741
11,642 New
11,642 $372 Million

Others Institutions Holding GEM

# of Institutions
164
Shares Held
27.7M
Call Options Held
0
Put Options Held
0
View Full List

About GOLDMAN SACHS ETF TR ACTVEBETA

GEM Quotes by TradingView
  • Ticker GEM
  • Sector ETFs
  • Industry ETFs
More about GEM
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email